Ulcerative colitis trials in Romania

In Romania 14 Also abroad 382

14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
Where
Bucharest, Cluj-Napoca, Ploiesti, Timișoara
Age
18 years and over
People
593 worldwide
Run by
Eli Lilly & Co.
See details and how to join2023-507853-13-00 · EU 2023-507853-13-00
Phase 2Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Bucharest, Cluj-Napoca, Constanța, Timișoara
Age
18 years and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00
Phase 3Taking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Bacau, Bucharest, Constanța, Craiova, Timișoara
Age
18 years to 70 years
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
Phase 2Taking people
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Where
Bucharest, Constanța, Satu Mare, Timișoara
Age
18 years to 80 years
People
252 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07186101
Phase 3Taking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Bucharest, Cluj-Napoca, Jassi, Timișoara
Age
18 years and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00
Phase 1/2Taking people
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Where
Bragadiru, Bucharest, Cluj-Napoca, Ploieşti, Timișoara
Age
18 years to 75 years
People
270 worldwide
Run by
Xencor, Inc.
See details and how to joinNCT06619990
Phase 2Taking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Bucharest, Cluj-Napoca, Constanța, Timișoara
Age
18 years to 75 years
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
Phase 3Taking people
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
Where
Bucharest, Timișoara
Age
Up to 17 years
People
68 worldwide
Run by
Alfasigma S.p.A.
See details and how to join2024-511458-32-00 · EU 2024-511458-32-00
Phase 2Taking people
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Bucharest, Constanța, Ploieşti, Timișoara
Age
18 years to 75 years
People
204 worldwide
Run by
Palisade Bio
See details and how to joinNCT07845487
Phase 3Taking people
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Where
Bucharest, Timișoara
Age
8 years to 18 years
People
80 worldwide
Run by
Alfasigma S.p.A.
See details and how to joinNCT06865417
Phase 3Taking people
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Bucharest, Timisoara
Age
2 years to 17 years
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00
Phase 2Taking people
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
Where
Bucharest, Constanța, Satu Mare, Timișoara
Age
18 years and over
People
75 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-522338-30-00 · EU 2025-522338-30-00
Phase 3Taking people
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Where
Bucharest, Timisoara
Age
2 years to 17 years
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00
Phase 2Taking people
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Where
Bucharest, Timisoara
Age
18 years to 75 years
People
192 worldwide
Run by
Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00